Skip to content
Search

Latest Stories

NHS healthy living programme reduces Type 2 diabetes cases

NHS Diabetes Prevention Programme (NHS DPP) has helped to bring down the number of cases of Type 2 diabetes in England, a new research reveals. 

New data suggests the healthy living programme resulted in a seven per cent reduction in the number of new diagnoses of Type 2 diabetes in England between 2018 and 2019, with around 18,000 people saved the dangerous consequences of the condition.

Someone completing the nine month NHS scheme reduces their chances of getting the condition by more than a third (37 per cent), according to new University of Manchester research due to be presented at the annual Diabetes UK Professional Conference this week.


Prevention is a key part of the NHS Long Term Plan, which set out a major expansion of the Diabetes Prevention Programme.

Evidence has shown that the NHS spends around £10 billion a year on diabetes – around 10 per cent of its entire budget – and the NHS DPP is highly cost effective in the long-term.

Almost one million people have been referred to the programme since it was first launched in 2016, with participants who complete achieving an average weight loss of 3.3kg.

Since then, the NHS Long Term Plan expanded access so that up to 200,000 people a year will benefit as part of radical NHS action to tackle rising obesity rates and to prevent Type 2 diabetes.

The country’s top diabetes experts are expected to say that the programme will improve the health of hundreds of thousands of people.

Being diagnosed with Type 2 diabetes can have a devastating impact on people and their families – it is a leading cause of preventable sight loss in people of working age and is a major contributor to kidney failure, heart attack, stroke and many of the common types of cancer.

NHS National Clinical Director for Diabetes and Obesity, Professor Jonathan Valabhji, said: “The evidence is now clear – the NHS is preventing Type 2 diabetes and is helping thousands of people to lead healthier lives.

“Summer 2018 saw England become the first country to achieve universal coverage with such a programme. This latest evidence shows that the programme can have a major impact on peoples’ lives.”

Health and Social Care Secretary Sajid Javid said: “It is excellent to see the NHS Diabetes Prevention Programme, recently expanded as part of the NHS Long Term Plan, has helped 18,000 people avoid Type 2 diabetes – a serious and dangerous condition.

“It’s vital we focus on prevention and provide advice on healthy eating and exercise, as obesity can lead to a number of serious health conditions and is the second biggest cause of cancer in the UK.

“Programmes like this are helping people to live longer, healthier lives as part of our mission to level up the health of the nation and tackle disparities.”

More For You

Homecare medicines services face many challenges beyond pharmacy's control

Homecare medicines services face many challenges beyond pharmacy's control

gettyimages

GPhC calls for industry-wide collaboration to strengthen homecare medicines services

The General Pharmaceutical Council (GPhC) has called for industry-wide collaboration to improve homecare medicines services to ensure patients always receive their medicines when needed.

The call follows a recent review by the regulator, which identified several challenges facing homecare services, many of which were beyond the immediate control of the pharmacies providing them.

Keep ReadingShow less
Lack of funding deters NI pharmacy contractors from expanding portfolio

W G Hamilton Pharmacy is the third pharmacy in Northern Ireland to be recently sold to first-time buyers.

Pharmacy ownership trends shift in Northern Ireland due to funding gap

An increasing number of pharmacies in Northern Ireland are being acquired by first-time buyers, as existing contractors and groups pull back from expanding their portfolios amid ongoing funding pressures, according to specialist business property adviser Christie & Co.

Among the most recent sales is W G Hamilton Pharmacy, a busy community pharmacy in Ballysillan, North Belfast.

Keep ReadingShow less
RPS backs Pharmacist Support "Gift in Wills" initiative

The ‘Gift in Wills’ initiative is delivered in partnership with Bequeathed.

Photo credit: gettyimages

Leave a legacy: RPS partners with Pharmacist Support to promote ‘Gift in Wills’

The Royal Pharmaceutical Society (RPS) has announced its support for the ‘Gift in Wills’ initiative run by Pharmacist Support, coinciding with the charity’s birthday celebrations today (Tuesday 15 April).

This collaboration allows RPS members to create a free will while also helping to safeguard the future of vital support services for the pharmacy profession.

Keep ReadingShow less
Pharmacist Support calls for birthday donations to meet rising demand for mental health services

More and more pharmacy professionals are reaching out for help, said Danielle Hunt.

Pharmacist Support's birthday appeal: Donate to address growing mental health demand

Pharmacist Support – the independent charity dedicated to the pharmacy profession – is celebrating 184 years of service with the launch of a special birthday donations appeal.

On 15 April, the charity is urging individuals and organisations across the sector to support its campaign to raise vital funds to meet the increasing demand for its mental health and wellbeing services.

Keep ReadingShow less
Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less